Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...

The FTSE 100 index traded up 8.88 points, 0.1%, at 8,786.27. The FTSE 250 was 105.22 points higher, 0.5%, at 21,024.94, and the AIM All-Share rose just 0.34 of a point at 724.88.

The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

Other blue chips under pressure included Marks & Spencer, Barclays and Rolls-Royce, with their shares down by around 0.5%.

Deutsche Bank raises CMC Markets to 'hold' (sell) - price target 246 pence Barclays reinitiates Mulberry Group with 'equal weight' - price target 94 pence JPMorgan cuts Smurfit WestRock price target ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...

Pharmaceuticals giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” ...